Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Todd Neale

December 28, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

L.A. McKeown

November 21, 2022

News Daily News

Aortic Dissection Risk Rises With Thoracic Aneurysm Size: Large Network Study

Yael L. Maxwell

October 10, 2022

News Daily News

LivaNova Recalls Some LifeSPARC Controllers Used in Advanced Circulatory Support

L.A. McKeown

September 30, 2022

News Daily News

Another DOAC Fails in the Setting of Mechanical Heart Valves

Todd Neale

September 28, 2022

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

Presentation Interventional Complications 2022

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

Presenter: Frederick Welt

July 15, 2022

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Daily News

Cardiac Rehab Can Be Safely Started 2 Weeks After Surgery: SCAR

Michael O'Riordan

June 24, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Daily News

Worse Survival for Women After Ruptured AAA Repair

L.A. McKeown

May 11, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

Advertisement

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

December 2022 News Roundup

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

Aortic Dissection Risk Rises With Thoracic Aneurysm Size: Large Network Study

LivaNova Recalls Some LifeSPARC Controllers Used in Advanced Circulatory Support

Another DOAC Fails in the Setting of Mechanical Heart Valves

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

September 2022 News Roundup

August 2022 News Roundup

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Cardiac Rehab Can Be Safely Started 2 Weeks After Surgery: SCAR

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Worse Survival for Women After Ruptured AAA Repair

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content